Dysmetabolic iron overload syndrome (DIOS)

Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased tr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:La Presse médicale (1983) 2017-12, Vol.46 (12), p.e306-e311
Hauptverfasser: Deugnier, Yves, Bardou-Jacquet, Édouard, Lainé, Fabrice
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e311
container_issue 12
container_start_page e306
container_title La Presse médicale (1983)
container_volume 46
creator Deugnier, Yves
Bardou-Jacquet, Édouard
Lainé, Fabrice
description Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.
doi_str_mv 10.1016/j.lpm.2017.05.036
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1968445979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S075549821730458X</els_id><sourcerecordid>1968445979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlZ_gBuZZRVmTDKPJLiS1keh0IW6DknmDqTMTGoyLfTfm9Lq0tXdfOdw7ofQLcEZwaR6XGftpssoJizDZYbz6gyNKSV5iimrztEYs7JMC8HpCF2FsMaYkoKJSzSiglSCETxGD_N96GBQ2rXWJNa7PnE78K1TdRL2fe1dB8l0vlh93F-ji0a1AW5Od4K-Xl8-Z-_pcvW2mD0vU1PQfEh5U2vVKCNYA7TUghe8oabWWuS6BGBMMU5yoIZTYQipNMNxs65YEQnKIZ-g6bF34933FsIgOxsMtK3qwW2DJKLiRVEKJiJKjqjxLgQPjdx42ym_lwTLgyK5llGRPCiSuJRRUczcneq3uoP6L_HrJAJPRwDikzsLXgZjoTdQWw9mkLWz_9T_APatdWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1968445979</pqid></control><display><type>article</type><title>Dysmetabolic iron overload syndrome (DIOS)</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</creator><creatorcontrib>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</creatorcontrib><description>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</description><identifier>ISSN: 0755-4982</identifier><identifier>EISSN: 2213-0276</identifier><identifier>DOI: 10.1016/j.lpm.2017.05.036</identifier><identifier>PMID: 29169710</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Humans ; Iron Overload - complications ; Iron Overload - diagnosis ; Iron Overload - physiopathology ; Iron Overload - therapy ; Metabolic Syndrome - complications ; Metabolic Syndrome - diagnosis ; Metabolic Syndrome - physiopathology ; Metabolic Syndrome - therapy</subject><ispartof>La Presse médicale (1983), 2017-12, Vol.46 (12), p.e306-e311</ispartof><rights>2017 Elsevier Masson SAS</rights><rights>Copyright © 2017 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</citedby><cites>FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</cites><orcidid>0000-0002-2796-2571</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lpm.2017.05.036$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29169710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deugnier, Yves</creatorcontrib><creatorcontrib>Bardou-Jacquet, Édouard</creatorcontrib><creatorcontrib>Lainé, Fabrice</creatorcontrib><title>Dysmetabolic iron overload syndrome (DIOS)</title><title>La Presse médicale (1983)</title><addtitle>Presse Med</addtitle><description>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</description><subject>Humans</subject><subject>Iron Overload - complications</subject><subject>Iron Overload - diagnosis</subject><subject>Iron Overload - physiopathology</subject><subject>Iron Overload - therapy</subject><subject>Metabolic Syndrome - complications</subject><subject>Metabolic Syndrome - diagnosis</subject><subject>Metabolic Syndrome - physiopathology</subject><subject>Metabolic Syndrome - therapy</subject><issn>0755-4982</issn><issn>2213-0276</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEUhYMotlZ_gBuZZRVmTDKPJLiS1keh0IW6DknmDqTMTGoyLfTfm9Lq0tXdfOdw7ofQLcEZwaR6XGftpssoJizDZYbz6gyNKSV5iimrztEYs7JMC8HpCF2FsMaYkoKJSzSiglSCETxGD_N96GBQ2rXWJNa7PnE78K1TdRL2fe1dB8l0vlh93F-ji0a1AW5Od4K-Xl8-Z-_pcvW2mD0vU1PQfEh5U2vVKCNYA7TUghe8oabWWuS6BGBMMU5yoIZTYQipNMNxs65YEQnKIZ-g6bF34933FsIgOxsMtK3qwW2DJKLiRVEKJiJKjqjxLgQPjdx42ym_lwTLgyK5llGRPCiSuJRRUczcneq3uoP6L_HrJAJPRwDikzsLXgZjoTdQWw9mkLWz_9T_APatdWQ</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Deugnier, Yves</creator><creator>Bardou-Jacquet, Édouard</creator><creator>Lainé, Fabrice</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2796-2571</orcidid></search><sort><creationdate>201712</creationdate><title>Dysmetabolic iron overload syndrome (DIOS)</title><author>Deugnier, Yves ; Bardou-Jacquet, Édouard ; Lainé, Fabrice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-8fdbafac97fe25b9848f2cdbb93b5ee77a7813e2c829c116b70221b674b9328e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Humans</topic><topic>Iron Overload - complications</topic><topic>Iron Overload - diagnosis</topic><topic>Iron Overload - physiopathology</topic><topic>Iron Overload - therapy</topic><topic>Metabolic Syndrome - complications</topic><topic>Metabolic Syndrome - diagnosis</topic><topic>Metabolic Syndrome - physiopathology</topic><topic>Metabolic Syndrome - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deugnier, Yves</creatorcontrib><creatorcontrib>Bardou-Jacquet, Édouard</creatorcontrib><creatorcontrib>Lainé, Fabrice</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>La Presse médicale (1983)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deugnier, Yves</au><au>Bardou-Jacquet, Édouard</au><au>Lainé, Fabrice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysmetabolic iron overload syndrome (DIOS)</atitle><jtitle>La Presse médicale (1983)</jtitle><addtitle>Presse Med</addtitle><date>2017-12</date><risdate>2017</risdate><volume>46</volume><issue>12</issue><spage>e306</spage><epage>e311</epage><pages>e306-e311</pages><issn>0755-4982</issn><eissn>2213-0276</eissn><abstract>Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29169710</pmid><doi>10.1016/j.lpm.2017.05.036</doi><orcidid>https://orcid.org/0000-0002-2796-2571</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0755-4982
ispartof La Presse médicale (1983), 2017-12, Vol.46 (12), p.e306-e311
issn 0755-4982
2213-0276
language eng
recordid cdi_proquest_miscellaneous_1968445979
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Humans
Iron Overload - complications
Iron Overload - diagnosis
Iron Overload - physiopathology
Iron Overload - therapy
Metabolic Syndrome - complications
Metabolic Syndrome - diagnosis
Metabolic Syndrome - physiopathology
Metabolic Syndrome - therapy
title Dysmetabolic iron overload syndrome (DIOS)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T08%3A07%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysmetabolic%20iron%20overload%20syndrome%20(DIOS)&rft.jtitle=La%20Presse%20m%C3%A9dicale%20(1983)&rft.au=Deugnier,%20Yves&rft.date=2017-12&rft.volume=46&rft.issue=12&rft.spage=e306&rft.epage=e311&rft.pages=e306-e311&rft.issn=0755-4982&rft.eissn=2213-0276&rft_id=info:doi/10.1016/j.lpm.2017.05.036&rft_dat=%3Cproquest_cross%3E1968445979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1968445979&rft_id=info:pmid/29169710&rft_els_id=S075549821730458X&rfr_iscdi=true